Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 2024-08-19 20:00
China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split 2024-02-24 05:05
China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device 2023-11-29 21:00
China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs 2023-08-09 20:30
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split 2023-02-25 05:05
China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask 2022-12-28 21:00
China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19 2022-12-15 21:00
China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project 2022-12-05 21:00
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-12-03 05:10
China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency 2022-10-02 10:05
China Pharma Announced the Submission of a Plan of Compliance to NYSE American 2022-07-18 20:00
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-06-23 05:00
China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results 2022-03-31 20:00
China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results 2021-11-13 05:30
China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results 2021-08-14 04:30
China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval 2021-08-05 21:00
China Pharma to Launch Highly Purified NMN+PQQ Product 2021-06-09 20:00
China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue 2021-05-15 04:30
China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port 2021-04-19 20:30
China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results 2021-03-27 05:00
1 2 3 4 5 7